A New HPV Laboratory in Rwanda Marks a Major Step Forward in Cervical Cancer Prevention

One of the biggest challenges in cervical cancer prevention is not only reaching women for screening, but also ensuring laboratories can process tests quickly and efficiently at scale.

As HPV screening programs grow, laboratory capacity becomes critical. Delays in testing can slow down diagnosis, treatment decisions, and the effectiveness of national prevention strategies.

To help address this challenge, GYNIUS has successfully established a new HPV laboratory in Gicumbi District, Rwanda — strengthening local testing capacity and supporting faster, high-volume cervical cancer screening.

The laboratory initiative was made possible through collaboration between organizations committed to improving access to women’s healthcare in Rwanda.

GYNIUS extends its gratitude to the Elekta Foundation for its initiative and continued support in advancing cervical cancer prevention efforts. We also thank the Rwanda Biomedical Center (RBC) and the Rwanda National Reference Laboratory for their technical guidance, partnership, and collaboration throughout the implementation process.

Special appreciation also goes to the Society for Family Health (SFH), whose community health workers and management teams continue to play a vital role in mobilization, coordination, and local implementation efforts.

With the HPV laboratory now operational in Gicumbi District, the program aims to complete HPV testing for 35,000 women within a three-month period using locally trained teams and healthcare professionals.

This large-scale effort represents an important step toward improving screening accessibility and reducing testing turnaround times for women across the region.

The initiative combines high-capacity sampling with improved laboratory efficiency, helping healthcare providers manage larger testing volumes while maintaining effective screening workflows.

Beyond testing infrastructure, the project also focuses on empowering local healthcare systems.

By working closely with local teams, healthcare institutions, and field workers, the initiative contributes to long-term sustainability and strengthens Rwanda’s ability to continue expanding cervical cancer prevention programs nationwide.

The establishment of the laboratory reflects a growing commitment to building scalable healthcare solutions that can support both present and future screening demands.

Cervical cancer remains one of the most preventable forms of cancer when detected early. Expanding access to HPV testing, strengthening laboratory systems, and supporting local healthcare teams are all essential parts of achieving that goal.

Through innovation, collaboration, and shared commitment, GYNIUS and its partners continue working toward a future where cervical cancer can be eliminated.

Together, we move one step closer.